NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions

NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.